Latest news with #JayPatel
Time of India
4 days ago
- Sport
- Time of India
Three caught selling IPL final tickets at higher rates
Ahmedabad: City police on Sunday filed two separate complaints after catching three persons selling tickets for the IPL 2025 final match at inflated prices near Narendra Modi Stadium in Motera and Commerce Six Roads. In the first case, Chandkheda cops were patrolling near the stadium when they received a tip-off. The informer said that a man and a woman, standing near Ekta Hotel outside Gate 1 of Narendra Modi Cricket Stadium, were selling tickets for the final match to be held on 3 June. The cops approached the suspects and found that they were trying to sell the tickets. Police cordoned the area and detained them. The two identified themselves as Jay Patel and Vagmi Patel, both aged 27, and residents of Vasna. They were found with eight tickets, each originally priced at Rs 2,500. Jay and Vagmi admitted that they intended to sell each ticket for Rs 7,000. A mobile phone and the tickets were seized from them. In the second case, Crime Branch police received information about a man selling tickets near Commerce Six Roads. Cops and witnesses reached the spot near metro pillar number CP/184 at Commerce Six Roads and found a man matching the informer's description. He was detained and identified as Bhavuk Chauhan, a native of Rajasthan, currently living in Ahmedabad. A search found 11 tickets with him, originally priced at Rs 1,500 and Rs 2,000. Chauhan admitted he was selling them for Rs 5,000 and Rs 6,000 each. All three individuals were booked for selling tickets illegally under the Gujarat Police Act.
BBC News
4 days ago
- General
- BBC News
Hospital could not stop disabled man's death, inquest hears
A disabled man who died in a London hospital after his parents could not get a second opinion would not have survived either way, a coroner's court has Patel, 30, from Finchley in north London, died on 9 August 2023 at St Thomas' Hospital after his lungs became father Jay Patel told an inquest that Balram should have been treated with intravenous diuretics but the hospital gave him oral diuretics instead, which had previously shown to not be as effective on Yaso Emmanuel, consultant cardiologist at Guy's and St Thomas' NHS Foundation Trust, said Balram's condition had been worsening from the start of 2023 and that "nobody could prevent him from dying". 'Exhausted other routes' Balram had multiple disabilities and was developmentally delayed. He was born with half a functioning heart and had liver cancer at the time of was admitted to St Thomas' in July 2023 with a raised infection rate and then suffered fluid build-up. It was later decided he should be transferred home due to his vulnerabilities after a Covid outbreak at the evidence at the inquest, Dr Emmanuel said it was only possible for Balram to be been sent home if oral - rather than intravenous - diuretics were administered."We had exhausted other routes," she told the coroner's court. "We looked to see if community teams providing care could support intravenous diuretics but the message we received was that they couldn't."The hospital conducted a series of tests in July, including blood tests and scans on his liver."Hospital treatment wouldn't have altered the ultimate prognosis," Dr Emmanuel said. "We knew how limited his remaining time was. By that stage, he was in a very different position medically from where he had been the rest of his life."She added: "I didn't expect him to deteriorate quite so quickly on oral diuretics. But to me that's a sign his heart condition had worsened."Mr Patel, representing himself, said earlier witness statements had stated that Balram could have lived longer if he had been administered intravenous rather than oral diuretics. He said: "When Balram was born, doctors said he had three weeks to live. He lived for thirty years after that."He asked Dr Emmanuel: "Do you recall me asking for a second opinion?" She said she could not inquest at London Inner South Coroner's Court in Southwark continues.
Hans India
13-05-2025
- Health
- Hans India
Savarkar Movie Actor Becomes Real-Life Healthcare Hero in New York
On April 30, 2025, an inspiring and emotionally resonant ceremony was held in New York City to celebrate the 2025 Healthcare Heroes—individuals recognized for their extraordinary contributions to the field of healthcare. Among the distinguished honourees was Jay Patel, Chairman of Med Data Science Inc. and actor known for portraying Shyamji Krishna Varma in the acclaimed film Swatantrya Veer Savarkar. On this occasion, reel met real as Patel was honoured not for his cinematic work, but for his tangible, life-changing contributions to healthcare. Notably, he was the only honouree of Indian origin at the event. Patel's humanitarian impact goes beyond innovation. During the COVID-19 pandemic, he collaborated with philanthropist Paresh Ghelani to distribute over $2 million worth of sanitizer across New York, Chicago, and various regions in India. He also made a contribution to the PM CARES Fund. Further showing his commitment, Patel personally ensured that 800 people received food and essential supplies for over six months, driven purely by compassion and civic duty. In recognition of this commitment, New York State Senator Joseph P. Addabbo, Jr. formally congratulated Patel: 'The New York State Senate recognizes and congratulates Jay Patel for being honoured for his outstanding dedication as a Healthcare Hero—one who has given selflessly and tirelessly to the State of New York and who has served the state and this community with loyalty and dedication…' That same day, Patel was also honoured by Nassau County Executive Bruce A. Blakeman, who presented him with a County Citation for his exemplary public service and humanitarian contributions. A Tribute to Healthcare Mentors and Visionaries Jay Patel took a moment during the ceremony to express gratitude and reverence for several leading medical professionals who inspired his path and whose dedication to humanity and public health continue to guide his vision: • Dr. Navneet Shah – Diabetologist & Endocrinologist • Dr. Shailesh Talati – Senior Hematologist, Medical Oncology • Prof. Dr. Tejas Madhusudan Patel – Interventional Cardiologist • Dr. Sewanti Limaye – Director of Medical & Precision Oncology • Dr. Kalpesh Ghelani – Chiropractic Specialist • Dr. Hital Patel – Dermatologist • Dr. Pinakin J. Shah – Surgical Oncologist 'Each of these doctors has played a key role in shaping the future of healthcare, not just through treatment, but through unwavering compassion and commitment to society,' Med Data Science and the Vision Ahead Under Patel's leadership, Med Data Science Inc. is revolutionizing medical billing and coding using AI technologies that promote efficiency, transparency, and speed. The company also aims to expand access to care for uninsured patients—a rare mission in today's profit-driven medical world. Patel's co-leaders at Med Data Science, Chief Technology Officer Mudit Sachdev and Chief Operating Officer Payal Patel, both attended the event and shared, 'It's a proud moment to see someone from our team honoured not only for innovation but for uplifting humanity.' Other Notable Honourees at the 2025 Healthcare Heroes Awards • Dr. Navarra Rodriguez • Sr. Philip Ann – The Carmelite System • Kahoney Anderson – St. Patrick's Manor Nursing and Rosarie Center • Dr. Abbi-Gail Baboolal – NYC Health + Hospitals/Queens • Daniele Bernard – Life's WORC • Dr. Jeffrey M. Birnbaum – SUNY Downstate Health Sciences University • Cristina Contreras – NYC Health + Hospitals/Lincoln (ICON/TRAILBLAZER AWARD) • Dr. Marilyn Fraser – Arthur Ashe Institute • Dr. Dene T. Hurley – Lehman College • Julian John – NYC Health + Hospitals/Metropolitan (VANGUARD AWARD) • Dr. Ross MacDonald – NYC Health + Hospitals/Woodhull Jay Patel's recognition at the Healthcare Heroes Awards affirms his dedication to building a future where innovation, empathy, and equity go hand in hand.
The Guardian
02-04-2025
- Health
- The Guardian
Could antibiotics stop working? Yes – but the biggest danger isn't prescription-happy GPs
If the antibiotics we use to treat infections ever stopped working, the consequences would be catastrophic. It is estimated that the use of antibiotics adds about 20 years of life expectancy for every person worldwide (on average). As the King's Fund put it, if we lose antibiotics, 'we would lose modern medicine as we know it'. Doctors, public health experts and governments take the threat of antimicrobial resistance (AMR) very seriously, yet the problem appears to be getting worse. A report from the National Audit Office in February finds that out of five domestic targets set in 2019 to tackle AMR, only one has been met – to reduce antibiotic use in food-producing animals. Others, such as the target to reduce drug-resistant infections in humans by 10%, haven't made much progress; in fact, these infections have actually increased by 13% since 2018. AMR is often misunderstood. I have often heard people say 'I'm afraid of taking antibiotics and becoming resistant to them.' But AMR isn't about individuals becoming resistant to antibiotics. It's about pathogens – most often bacterial infections but also viruses, fungi and parasites – evolving to become resistant to our current drugs, so that the infections they cause become untreatable. Think of ear, urinary tract and chest infections, or procedures such as C-sections and other routine surgeries, becoming life threatening because the drugs we use to treat infections or to prevent them after medical procedures don't work. However, I despair at Britain beating itself with yet another stick. The country has actually been fairly good at tackling AMR. In 2023, our research team led by Jay Patel published an analysis in the Lancet Infectious Diseases journal measuring the global response to AMR in 114 countries. The UK made the top three 'best performing' countries with only the US and Norway ahead, followed by Sweden, Denmark, Germany and Japan. The credit in the UK largely sits with Dame Sally Davies, the chief medical officer for England from 2011 to 2019, who made it a priority during her tenure and continues to lead as the UK special envoy on AMR. The UK government has led on national guidelines and oversight in human and animal health in conjunction with the EU. We may worry about doctors overprescribing antibiotics in the NHS, needlessly exposing pathogens to these drugs and allowing them to evolve resistance. But having worked on AMR governance before, my take is that the biggest threat is the rise of resistant pathogens emerging in countries using huge amounts of antibiotics in their animals for growth and cheap meat. Think of pigs, chickens and cattle in China, Brazil, India and, even until recently, the US. Livestock alone is estimated to consume 50% to 80% of the antibiotics produced in high- and middle-income countries. These resistant pathogens develop in animals, which are given antibiotics as a prophylactic even when they're healthy. They then infect a human, who may travel and spread it to other humans. It is a straightforward formula. Antibiotics in animals plus farm workers plus air travel equals drug-resistant infections in the UK, and elsewhere. It is not just theoretical. In 2018, a study in Nature found that widespread colistin-resistant bacteria, including in hospitals in London, could be traced to a single event in 2006 in China when a bacteria jumped from pigs into humans. Colistin is a last-line antibiotic for certain infections, meaning it is given after other drugs have failed, yet it was used heavily for growth promotion in pig farming in China. Since these findings, the Chinese government, as well as India and Japan, banned colistin in animal feed. This probably will have a larger impact on reducing AMR than anything being done in UK clinics and with human prescribing practices. The UK is best protected from drug-resistant infections by working with other countries to regulate the use of antibiotics, especially in animals. Davies has tried hard to push this agenda globally, bringing together human health, agricultural and vet experts to agree on standards and regulations that are a universal good. However, there is a clear conflict with those who argue that boosting animal production, including of cheap and available meat, is the priority, especially in middle-income countries with large populations. Why can't we just develop new antibiotics if our current ones become ineffective? Simple question and tough answer. These are technically difficult drugs to develop and we have made very slow progress. Developing similar versions to existing antibiotics isn't enough because they won't be as effective against pathogens that have developed resistance: we need totally new classes of drugs. And a recent World Health Organization report noted that since 2017, while 13 new antibiotics have obtained authorisation, only two represent a new chemical class. Our best to shot to tackle AMR is to protect our current arsenal of drugs and make sure they remain effective. This means working with other countries on a shared approach to how and when drugs are used in humans and animals. This is an ongoing challenge, especially in a world where cooperation is breaking down and isolationist approaches are on the rise. Yes, we can blame the UK government for many things, but on the issue of AMR it is a standout country and a global leader. Prof Devi Sridhar is chair of global public health at the University of Edinburgh, and the author of How Not to Die (Too Soon)
